SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-027117
Filing Date
2013-05-08
Accepted
2013-05-08 17:01:30
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v341092_10q.htm 10-Q 322697
2 EXHIBIT 10.62 v341092_ex10-62.htm EX-10.62 56283
3 EXHIBIT 31.1 v341092_ex31-1.htm EX-31.1 10423
4 EXHIBIT 31.2 v341092_ex31-2.htm EX-31.2 10331
5 EXHIBIT 32.1 v341092_ex32-1.htm EX-32.1 5261
6 EXHIBIT 32.2 v341092_ex32-2.htm EX-32.2 5326
  Complete submission text file 0001144204-13-027117.txt   3076101

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pip-20130331.xml EX-101.INS 313466
8 XBRL TAXONOMY EXTENSION SCHEMA pip-20130331.xsd EX-101.SCH 33108
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pip-20130331_cal.xml EX-101.CAL 43621
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pip-20130331_def.xml EX-101.DEF 114472
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pip-20130331_lab.xml EX-101.LAB 471788
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pip-20130331_pre.xml EX-101.PRE 199576
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 13825317
SIC: 2834 Pharmaceutical Preparations